{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.196.11.1500","meta":{"versionId":"6","lastUpdated":"2018-03-10T01:00:08.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"NCQA PHEMUR Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2018-03-10"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1500","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.464.1003.196.11.1500"}],"version":"20180310","name":"DextromethorphanPhenylephrineTriprolidine","title":"Dextromethorphan / Phenylephrine / Triprolidine","status":"active","experimental":false,"date":"2018-03-10T01:00:08-05:00","publisher":"NCQA PHEMUR","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1492052","display":"Dextromethorphan Hydrobromide 4 MG/ML / Phenylephrine Hydrochloride 2 MG/ML / Triprolidine Hydrochloride 0.5 MG/ML Oral Solution"}]}]},"expansion":{"identifier":"urn:uuid:87ed84d2-3e04-4a1d-a1d4-6cec67971cd7","timestamp":"2023-12-11T02:33:32-05:00","total":1,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1492052","display":"dextromethorphan hydrobromide 4 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution"}]}}